每经记者|金喆 每经编辑|魏官红2011年,陈智胜博士从美国回到中国。与很多海归科学家选择创业不一样,陈智胜加入了药明康德,那时候,无锡马山到处都是隆隆作响的打桩声。2014年,药明生物从药明康德分拆,陈智胜担任药明生物CEO(首席执行官)。“我还记得有天晚上和几个同行在苏州BioBAY聊天,大家还在畅想,五年后中国可以有第一个自己的创新药、二十年后有5到10个创新药就不错了,那就非常好了。...
Source Link每经记者|金喆 每经编辑|魏官红2011年,陈智胜博士从美国回到中国。与很多海归科学家选择创业不一样,陈智胜加入了药明康德,那时候,无锡马山到处都是隆隆作响的打桩声。2014年,药明生物从药明康德分拆,陈智胜担任药明生物CEO(首席执行官)。“我还记得有天晚上和几个同行在苏州BioBAY聊天,大家还在畅想,五年后中国可以有第一个自己的创新药、二十年后有5到10个创新药就不错了,那就非常好了。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.